Failure to follow up on a medically actionable finding from direct to consumer genetic testing: A case report
Abstract Background A 61‐year‐old woman underwent direct to consumer genetic testing and was found to be homozygous for the C282Y HFE variant (c.845G>A :p.Cys282Tyr) which is classified as pathogenic/likely pathogenic for hereditary hemochromatosis. However, no action was taken by the individual....
Main Authors: | Ramin Garmany, Christopher J. Lee, Richard R. Sharp, Iftikhar J. Kullo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | Molecular Genetics & Genomic Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/mgg3.1252 |
Similar Items
-
Frequency of Three Hemochromatosis Gene Mutations in Antalya, Turkey
by: Oztürk S, et al.
Published: (2007-04-01) -
Juvenile Hemochromatosis: Rheumatic Manifestations of 2 Sisters Responding to Deferasirox Treatment. A Case Series and Literature Review
by: Alqanatish J, et al.
Published: (2021-01-01) -
Ancestral association between HLA and HFE H63D and C282Y gene mutations from northwest Colombia
by: Libia M Rodriguez, et al.
Published: (2015-03-01) -
Mutations in the HFE gene (C282Y, H63D, S65C) in a Brazilian population Mutações no gene HFE (C282Y, H63D, S65C) em uma população brasileira
by: Simone Bueno, et al.
Published: (2006-12-01) -
Therapeutic Erythrocytapheresis in the Initial Treatment of Hereditary Hemochromatosis
by: Vít Řeháček, et al.
Published: (2012-01-01)